loading

Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
1.80%
243.78
239.46 200.49 184.73 201.27
Cost Of Revenue
14.91%
68.55
59.65 38.15 31.99 54.41
Gross Profit
2.54%
175.23
179.81 162.34 152.74 146.86
Operating Expenses
19.56%
136.67
114.32 114.16 96.49 91.13
Benefits Costs and Expenses
18.06%
203.02
171.97 150.85 127.56 145.11
Costs And Expenses
18.06%
203.02
171.97 150.85 127.56 145.11
Operating Income/Loss
41.12%
38.56
65.49 48.18 56.24 55.73
Income/Loss From Continuing Operations Before Tax
39.61%
40.76
67.49 49.64 57.18 56.16
Income Tax Expense/Benefit
9.92%
18.27
16.62 9.861 11.62 6.68
Income/Loss From Continuing Operations After Tax
55.79%
22.49
50.87 39.78 45.56 49.48
Net Income/Loss
55.79%
22.49
50.87 39.78 45.56 49.48
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.28%
-0.163
57.55 57.47 57.31 0.0703
Diluted Average Shares
100.33%
-0.1938
58.72 58.43 58.52 0.1159
Basic Earnings Per Share
54.55%
0.40
0.88 0.69 0.79 0.87
Diluted Earnings Per Share
55.17%
0.39
0.87 0.68 0.78 0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):